Ototoxic therapeutic agents.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002701:Chloramphenicol / Q000009:adverse effects; D003638:Deafness / Q000139:chemically induced*; D004096:Dihydrostreptomycin Sulfate / Q000009:adverse effects; D004976:Ethacrynic Acid / Q000009:adverse effects; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007612:Kanamycin / Q000009:adverse effects; D009355:Neomycin / Q000009:adverse effects; D011247:Pregnancy; D011803:Quinine / Q000009:adverse effects; D012459:Salicylates / Q000009:adverse effects; D013307:Streptomycin / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D012459:Salicylates; D007612:Kanamycin; D002701:Chloramphenicol; D011803:Quinine; D009355:Neomycin; D004976:Ethacrynic Acid; D004096:Dihydrostreptomycin Sulfate; D013307:Streptomycin